Vasogen to also Raise $7.5 Million in Non-Dilutive Financing from Cervus LP MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ - Vasogen Inc.

Drugs prescribed for attention deficit hyperactivity disorder can induce hallucinations even when taken as directed, US government researchers announced on Monday.

EAST HANOVER, N.J., Nov.

EAST HANOVER, N.J., July 8 /PRNewswire/ -- A head-to-head study, published in the June Journal of Child and Adolescent Psychopharmacology, confirms that Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules offer greater improvements in managing symptoms of Attention Deficit/Hyperactivity Disorder compared with Concerta(R) (d,l- methylphenidate HCl) extended-release tablets at two hours post-dose, the primary study endpoint.

TORONTO, Oct. 22 /PRNewswire/ -- IntelliPharmaCeutics Ltd. (the "Company") today announced the following with regard to its generic drug commercialization activities. In late August of this year, we announced that the Company's operating affiliate IntelliPharmaCeutics Corp.